JP Morgan Healthcare Conference, San Francisco

January 7-10

12 December 2018

Positive Clinical Results for APD403 in CINV Published in Supportive Care in Cancer

PostGraduate Assembly in Anesthesiology (PGA), New York City

December 7-11

07 December 2018

New BARHEMSYS™ PDUFA date confirmed for 5 May 2019

21 November 2018

Positive BARHEMSYS™ Rescue Treatment Data Published In Anesthesiology

Jefferies London Healthcare Conference, London

November 14-15

06 November 2018

Acacia Pharma Resubmits BARHEMSYS™ New Drug Application

06 November 2018

Unaudited Results for the nine months to 30 September 2018

American Society of Anesthesiology (ASA) San Francisco, CA

 October 13-17

15 October 2018

Further update on FDA regulatory review of BARHEMSYS™ 

08 October 2018

Update on FDA regulatory review of BARHEMSYS™

Health Connect Partners (HCP), Los Angeles, CA

October 1-3

Future Pharma, Boston, MA

September 26-28

Integrated Delivery Network Summit and Reverse Expo (IDN), Phoenix, AZ

September 17-19

14 September 2018

Positive BARHEMSYS™ Phase 3 Treatment Data Published in Anesthesia & Analgesia

07 September 2018

Interim Results for the First Half Year 2018

SG2 Executive Summit, Chicago, IL

July 23-25

09 July 2018

Operating Update for the First Half 2018

02 July 2018

$30 Million Credit Facility with Hercules Technology Growth Capital Secured to Support Intended Commercialisation of BARHEMSYS™ in the US

LSX CEO Forum, London, England

June 27

American Society of Metabolic and Bariatric Surgery (ASMBS), New York City

June 14-16

Jefferies 2018 Healthcare Conference, New York City

June 5-8

2018 BIO international Convention, Boston, MA

June 4-7

American Society of Health-System Pharmacists (ASHP), Denver, CO

June 2-6

Bio€quity Europe, Ghent, Belgium

May 14-16